| Abstrakt: |
Keywords for this news article include: First Affiliated Hospital of Wenzhou Medical University, Zhejiang, People's Republic of China, Asia, Cancer, Genetics, Oncology, Multiple Myeloma, Paraproteinemias, Health and Medicine, Hemostatic Disorders, Hemorrhagic Disorders, Blood Protein Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Vascular Diseases and Conditions, Hematologic Diseases and Conditions. Keywords: Blood Protein Disorders; Cancer; Genetics; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemic and Lymphatic Diseases and Conditions; Hemorrhagic Disorders; Hemostatic Disorders; Immunoproliferative Disorders; Lymphoproliferative Disorders; Multiple Myeloma; Myeloma; Oncology; Paraproteinemias; Vascular Diseases and Conditions EN Blood Protein Disorders Cancer Genetics Health and Medicine Hematologic Diseases and Conditions Hematology Hemic and Lymphatic Diseases and Conditions Hemorrhagic Disorders Hemostatic Disorders Immunoproliferative Disorders Lymphoproliferative Disorders Multiple Myeloma Myeloma Oncology Paraproteinemias Vascular Diseases and Conditions 455 455 1 08/21/23 20230821 NES 230821 2023 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Research findings on multiple myeloma are discussed in a new report. Blood Protein Disorders, Cancer, Genetics, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Hemorrhagic Disorders, Hemostatic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Myeloma, Oncology, Paraproteinemias, Vascular Diseases and Conditions. [Extracted from the article] |
